Increased immunogenicity of surviving tumor cells enables cooperation between liposomal doxorubicin and IL-18
I. Alagkiozidis, A. Facciabene, C. Carpenito, F. Benencia, Z. Jonak, S. Adams, R. Carroll, P. Gimotty, R. Hammond, G. Danet-Desnoyers, C. June, D. Powell, G. Coukos
Journal of Translational Medicine